Prospective follow-up of 67 indinavir-experienced human immunodeficiency virus-infected and AIDS patients treated with the ritonavir/saquinavir combination

Clinical Infectious Diseases

Volumn 28, Issue 5, 1999, Pages 1184-1185

  Lallemand, F ^a   Adda, N ^a   Schneider, V ^a   Jacomet, C ^a   Salhi, Y ^a   Rozenbaum, W ^a  

^a HÔPITAL ROTHSCHILD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

INDINAVIR; RITONAVIR; SAQUINAVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBIOTIC SENSITIVITY; ARTICLE; DRUG CHOICE; DRUG EFFICACY; GASTROINTESTINAL TOXICITY; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENCE; LYMPHOCYTE COUNT; PRIORITY JOURNAL; VIRUS GENE;

EID: 0032909370     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/517781     Document Type: Article

References (5)

1. 1. Puig T, Bonjoch A, Ruiz L, et al. Usefulness of ritonavir and saquinavir combination therapy for HIV-advanced patients failing on indinavir [abstract no 1201]. In: Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto). Washington, DC: American Society for Microbiology, 1997.
2. 2. Decks S, Grant R, Horton C, Simmonds N, Follansbee S, Eastman S. Virologic effect of ritonavir (RTV) plus saquinavir (SQV) in subjects who have failed indinavir (IDV) [abstract no 1205]. In: Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto). Washington, DC: American Society for Microbiology, 1997.
3. 3. Kaufmann D, Pantaleo G, Sudre P, Telenti A. Swiss HIV cohort study. CD4-cell count in HIV-1-infected individuals remaining viraemic with highly active antiretroviral therapy (HAART), Lancet 1998;351:723-4.
4. 4. Lorenzi P, Yerly S, Abderrakim K, et al. Toxicity, efficacy, plasma drug concentrations, and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir. AIDS 1997;11:F95-9.
5. 5. Deeks SG, Grant RM, Beatty GW, Horton C, Detmer J, Eastman S. Activity of a ritonavir plus saquinavir-containing regimen in patients with virologic evidence of indinavir or ritonavir failure. AIDS 1998;12:F97-102.